|
Market Closed -
Australian S.E.
08:53:53 25/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.4150 AUD | -2.35% |
|
-7.78% | +3.75% |
| 09-16 | Lake Street Initiates Alterity Therapeutics at Buy With $10 Price Target | MT |
| 08-31 | Alterity Therapeutics Enters Underwriting Agreement for Exercise of up to 8.4 Million Listed Options | MT |
Company Valuation: Alterity Therapeutics Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 21.56 | 11.37 | 14 | 59.84 | 86.52 | 64.32 | - | - |
| Change | - | -47.27% | 23.14% | 327.48% | 44.59% | -25.66% | - | - |
| Enterprise Value (EV) 1 | 21.56 | 11.37 | 9.172 | 38.2 | 59.75 | 23.42 | 27.17 | 58.51 |
| Change | - | -47.27% | -19.31% | 316.5% | 56.4% | -60.8% | 16.01% | 115.34% |
| P/E | - | - | - | - | -5.17x | -3.04x | -0.38x | -5.19x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | - | - | -0.1x | -0x | 0.1x |
| Capitalization / Revenue | 6.11x | 4.45x | 4.81x | 11.3x | 22.6x | 135x | 32.5x | 26.2x |
| EV / Revenue | 6.11x | 4.45x | 3.15x | 7.24x | 15.6x | 49.3x | 13.7x | 23.9x |
| EV / EBITDA | - | - | -0.71x | -4.68x | -3.33x | -1.03x | -1.17x | -2.88x |
| EV / EBIT | -2.07x | -1.22x | -0.71x | -4.87x | -3.33x | -0.86x | -0.88x | -1.8x |
| EV / FCF | -2.53x | - | -1.07x | -5.11x | -3.7x | -1.07x | -1.26x | -3.19x |
| FCF Yield | -39.6% | - | -93.4% | -19.6% | -27% | -93.2% | -79.1% | -31.4% |
| Dividend per Share 3 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 3 | - | - | - | - | -0.1112 | -0.1367 | -1.1 | -0.08 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 3.528 | 2.554 | 2.909 | 5.278 | 3.832 | 0.4754 | 1.978 | 2.451 |
| EBITDA 1 | - | - | -12.95 | -8.155 | -17.94 | -22.78 | -23.3 | -20.3 |
| EBIT 1 | -10.42 | -9.321 | -12.97 | -7.839 | -17.94 | -27.12 | -30.98 | -32.57 |
| Net income 1 | -8.843 | -8.966 | -12.97 | -7.927 | -16.83 | -27.54 | -30.84 | -31.61 |
| Net Debt 1 | - | - | -4.826 | -21.64 | -26.77 | -40.9 | -37.15 | -5.813 |
| Reference price 3 | 0.6500 | 0.3500 | 0.2000 | 0.5000 | 0.5750 | 0.4150 | 0.4150 | 0.4150 |
| Nbr of stocks (in thousands) | 48,137 | 48,798 | 104,902 | 182,547 | 217,509 | 220,701 | - | - |
| Announcement Date | 8/31/22 A | 8/31/23 A | 8/29/24 A | 8/28/25 A | 8/28/26 A | - | - | - |
1AUD in Million2USD in Million3AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.04x | 49.27x | -1.03x | - | 64.32M | |
| 33.26x | 5.97x | 17.88x | 0.98% | 47.97B | |
| 34.82x | 3.35x | 14.46x | -.--% | 44.5B | |
| -21.07x | 227.64x | -22.77x | -.--% | 43.93B | |
| 47.27x | 5.47x | 29.96x | -.--% | 41.03B | |
| 26.85x | 7.74x | 19.93x | 0.42% | 29.85B | |
| 35.19x | 5.78x | 26.24x | -.--% | 17.27B | |
| 25.79x | 2.21x | 9.6x | 1.04% | 15.3B | |
| -61.04x | 9.99x | 243.78x | -.--% | 15.34B | |
| Average | 13.12x | 35.27x | 37.56x | 0.3% | 28.36B | |
| Weighted average by Cap. | 19.69x | 43.80x | 26.11x | 0.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ATH Stock
- Valuation Alterity Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
